Insulet Current Ratio 2007-2018 | PODD

Insulet current ratio from 2007 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Insulet Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.46B $0.12B 3.99
2018-09-30 $0.45B $0.10B 4.58
2018-06-30 $0.42B $0.08B 5.54
2018-03-31 $0.45B $0.08B 5.48
2017-12-31 $0.54B $0.09B 6.24
2017-09-30 $0.37B $0.08B 4.88
2017-06-30 $0.34B $0.05B 7.06
2017-03-31 $0.34B $0.04B 8.56
2016-12-31 $0.37B $0.06B 6.64
2016-09-30 $0.36B $0.05B 6.67
2016-06-30 $0.18B $0.06B 3.29
2016-03-31 $0.17B $0.05B 3.45
2015-12-31 $0.19B $0.07B 2.93
2015-09-30 $0.19B $0.06B 3.27
2015-06-30 $0.20B $0.05B 3.87
2015-03-31 $0.21B $0.05B 4.34
2014-12-31 $0.21B $0.04B 4.70
2014-09-30 $0.21B $0.05B 4.33
2014-06-30 $0.23B $0.07B 3.26
2014-03-31 $0.20B $0.04B 4.64
2013-12-31 $0.20B $0.04B 4.68
2013-09-30 $0.20B $0.05B 4.14
2013-06-30 $0.20B $0.03B 5.82
2013-03-31 $0.20B $0.04B 4.53
2012-12-31 $0.11B $0.05B 2.28
2012-09-30 $0.11B $0.05B 2.32
2012-06-30 $0.12B $0.04B 2.70
2012-03-31 $0.13B $0.03B 3.94
2011-12-31 $0.13B $0.03B 4.74
2011-09-30 $0.14B $0.03B 5.57
2011-06-30 $0.15B $0.03B 5.56
2011-03-31 $0.13B $0.02B 7.95
2010-12-31 $0.14B $0.02B 7.52
2010-09-30 $0.13B $0.02B 6.52
2010-06-30 $0.15B $0.02B 6.13
2010-03-31 $0.14B $0.02B 7.93
2009-12-31 $0.15B $0.02B 7.79
2009-09-30 $0.10B $0.02B 5.48
2009-06-30 $0.08B $0.02B 4.79
2009-03-31 $0.10B $0.02B 5.05
2008-12-31 $0.09B $0.02B 5.22
2008-09-30 $0.11B $0.02B 6.70
2008-06-30 $0.13B $0.02B 8.04
2008-03-31 $0.09B $0.03B 3.49
2007-12-31 $0.11B $0.02B 5.17
2007-09-30 $0.11B $0.02B 5.90
2007-06-30 $0.13B $0.02B 7.50
2007-03-31 $0.03B $0.04B 0.67
2006-12-31 $0.04B $0.04B 1.02
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.00
2006-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.935B $0.564B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $128.012B 24.96
Medtronic (MDT) Ireland $113.636B 16.61
Stryker (SYK) United States $67.248B 24.66
Boston Scientific (BSX) United States $48.542B 23.59
Baxter (BAX) United States $38.022B 24.39
Zimmer Biomet Holdings (ZBH) United States $24.486B 15.67
Smith & Nephew SNATS (SNN) United Kingdom $16.790B 0.00
Canopy Growth (CGC) Canada $14.340B 0.00
ResMed (RMD) United States $13.953B 26.46
Aurora Cannabis (ACB) Canada $9.078B 64.00
Bio-Rad Laboratories (BIO) United States $8.696B 49.88
Perrigo (PRGO) Ireland $6.775B 10.98
Hill-Rom Holdings (HRC) United States $6.356B 19.66
GW Pharmaceuticals (GWPH) United Kingdom $4.697B 0.00
ICU Medical (ICUI) United States $4.641B 28.74
Haemonetics (HAE) United States $4.169B 36.99
Hutchison China MediTech (HCM) China $4.067B 0.00
Agios Pharmaceuticals (AGIO) United States $3.290B 0.00
Neogen (NEOG) United States $2.877B 46.77
NuVasive (NUVA) United States $2.794B 24.27
Quidel (QDEL) United States $2.380B 21.30
National Vision Holdings (EYE) United States $2.239B 44.05
Aphria (APHA) $1.960B 0.00
HEXO (HEXO) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.345B 19.33
VAREX IMAGING (VREX) United States $1.192B 23.34
Cardiovascular Systems (CSII) United States $1.182B 848.25
AtriCure (ATRC) United States $1.052B 0.00
Omeros (OMER) United States $0.928B 0.00
Lantheus Holdings (LNTH) United States $0.921B 24.90
PetIQ (PETQ) United States $0.851B 24.36
MacroGenics (MGNX) United States $0.798B 0.00
Cerus (CERS) United States $0.794B 0.00
NanoString Technologies (NSTG) United States $0.741B 0.00
TG Therapeutics (TGTX) United States $0.716B 0.00
Evolus (EOLS) United States $0.659B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.656B 22.33
OraSure Technologies (OSUR) United States $0.593B 25.81
Surmodics (SRDX) United States $0.543B 79.00
LeMaitre Vascular (LMAT) United States $0.532B 25.29
Meridian Bioscience (VIVO) United States $0.531B 15.81
Quanterix (QTRX) United States $0.478B 0.00
Insys Therapeutics (INSY) United States $0.320B 0.00
Utah Medical Products (UTMD) United States $0.316B 20.57
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.309B 0.00
BioLife Solutions (BLFS) United States $0.308B 126.92
Vapotherm (VAPO) United States $0.289B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.228B 3.12
Cytosorbents (CTSO) United States $0.224B 0.00
Zynex (ZYXI) United States $0.171B 18.28
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.124B 0.00
Fonar (FONR) United States $0.123B 6.60
Surface Oncology (SURF) United States $0.111B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
United-Guardian (UG) United States $0.086B 19.81
Female Health (VERU) United States $0.081B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Neurotrope (NTRP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 20.34
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.033B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.021B 0.00
Myomo (MYO) United States $0.020B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.03